Skip to main content
. 2023 Jul 6;10:1174372. doi: 10.3389/fmed.2023.1174372

Table 2.

Treatment characteristics and treatment response in Cohort A and Cohort B treated with standard therapy (oral steroids) and ozone therapy.

Patient characteristics Cohort A (Steroid therapy only) (n = 23) Cohort B (Steroid therapy and ozone therapy) (n = 24) Value of p
Median follow-up time (months) 12 (range, 12–35) 13 (range, 12–23) 0.447*
Number of ozone applications NA 16 (range, 10–25)
Median week of steroid use 26 (range, 16–36) 12 (range, 8–32) 0.001
Median maximum methyl prednisolone dose per day 16 mg (range, 8–32) 16 mg (range, 8–32) 0.650
Response to four-month therapy after diagnosis 0.005
Complete response rate 0% (0/23) 37.5% (9/24)
Partial response (>50% disappearance of lesions) 65.2% (15/23) 54.2% (13/24)
Minimal response (<50% disappearance of lesions) 30.4% (7/23) 8.3% (2/24)
No response/progression 4.3% (1/23) 0% (0/24)
Complete response rate 0% (0/23) 37.5% (9/24) 0.002
One-year breast recurrence rate 70% (16/23) 21% (5/24) 0.001
Two-year breast recurrence rate 73.9% (17/23) 29.2% (7/24) 0.003

*Mann–Whitney U-test was used. N.A. = not applicable.